Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enzalutamide (xtandi) (1 trial)
for46 (3 trials)
64cu-dota-daratumumab (1 trial)
ys5 antibody (1 trial)
Multiple Myeloma (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Prostatic Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (4 total)